IBDEI0F9 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19287,1,3,0)
 ;;=3^Malig Neop Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,19287,1,4,0)
 ;;=4^C34.90
 ;;^UTILITY(U,$J,358.3,19287,2)
 ;;=^5000966
 ;;^UTILITY(U,$J,358.3,19288,0)
 ;;=C65.9^^55^788^150
 ;;^UTILITY(U,$J,358.3,19288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19288,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,19288,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,19288,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,19289,0)
 ;;=C50.912^^55^788^131
 ;;^UTILITY(U,$J,358.3,19289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19289,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,19289,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,19289,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,19290,0)
 ;;=C50.911^^55^788^153
 ;;^UTILITY(U,$J,358.3,19290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19290,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,19290,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,19290,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,19291,0)
 ;;=C50.919^^55^788^123
 ;;^UTILITY(U,$J,358.3,19291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19291,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,19291,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,19291,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,19292,0)
 ;;=C62.90^^55^788^161
 ;;^UTILITY(U,$J,358.3,19292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19292,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,19292,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,19292,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,19293,0)
 ;;=D03.9^^55^788^165
 ;;^UTILITY(U,$J,358.3,19293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19293,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,19293,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,19293,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,19294,0)
 ;;=C45.0^^55^788^166
 ;;^UTILITY(U,$J,358.3,19294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19294,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,19294,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,19294,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,19295,0)
 ;;=C90.01^^55^788^168
 ;;^UTILITY(U,$J,358.3,19295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19295,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,19295,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,19295,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,19296,0)
 ;;=C90.00^^55^788^169
 ;;^UTILITY(U,$J,358.3,19296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19296,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,19296,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,19296,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,19297,0)
 ;;=C94.6^^55^788^170
 ;;^UTILITY(U,$J,358.3,19297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19297,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,19297,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,19297,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,19298,0)
 ;;=D61.82^^55^788^171
 ;;^UTILITY(U,$J,358.3,19298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19298,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,19298,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,19298,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,19299,0)
 ;;=D47.9^^55^788^172
 ;;^UTILITY(U,$J,358.3,19299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19299,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,19299,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,19299,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,19300,0)
 ;;=D53.9^^55^788^176
 ;;^UTILITY(U,$J,358.3,19300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19300,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,19300,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,19300,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,19301,0)
 ;;=D47.4^^55^788^177
 ;;^UTILITY(U,$J,358.3,19301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19301,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,19301,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,19301,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,19302,0)
 ;;=D59.1^^55^788^28
 ;;^UTILITY(U,$J,358.3,19302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19302,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,19302,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,19302,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,19303,0)
 ;;=D51.3^^55^788^191
 ;;^UTILITY(U,$J,358.3,19303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19303,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,19303,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,19303,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,19304,0)
 ;;=D77.^^55^788^57
 ;;^UTILITY(U,$J,358.3,19304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19304,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,19304,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,19304,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,19305,0)
 ;;=D58.2^^55^788^83
 ;;^UTILITY(U,$J,358.3,19305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19305,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,19305,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,19305,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,19306,0)
 ;;=C88.8^^55^788^103
 ;;^UTILITY(U,$J,358.3,19306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19306,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,19306,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,19306,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,19307,0)
 ;;=D70.8^^55^788^174
 ;;^UTILITY(U,$J,358.3,19307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19307,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,19307,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,19307,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,19308,0)
 ;;=D59.4^^55^788^175
 ;;^UTILITY(U,$J,358.3,19308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19308,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,19308,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,19308,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,19309,0)
 ;;=D69.59^^55^788^181
 ;;^UTILITY(U,$J,358.3,19309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19309,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,19309,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,19309,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,19310,0)
 ;;=C22.7^^55^788^46
 ;;^UTILITY(U,$J,358.3,19310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19310,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,19310,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,19310,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,19311,0)
 ;;=D75.89^^55^788^56
 ;;^UTILITY(U,$J,358.3,19311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19311,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,19311,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,19311,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,19312,0)
 ;;=D47.Z9^^55^788^173
 ;;^UTILITY(U,$J,358.3,19312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19312,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,19312,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,19312,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,19313,0)
 ;;=D05.82^^55^788^34
 ;;^UTILITY(U,$J,358.3,19313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19313,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,19313,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,19313,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,19314,0)
 ;;=D05.81^^55^788^36
 ;;^UTILITY(U,$J,358.3,19314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19314,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,19314,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,19314,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,19315,0)
 ;;=D05.80^^55^788^38
 ;;^UTILITY(U,$J,358.3,19315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19315,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,19315,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,19315,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,19316,0)
 ;;=D56.8^^55^788^186
 ;;^UTILITY(U,$J,358.3,19316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19316,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,19316,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,19316,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,19317,0)
 ;;=C82.89^^55^788^76
 ;;^UTILITY(U,$J,358.3,19317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19317,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,19317,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,19317,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,19318,0)
 ;;=D51.8^^55^788^193
 ;;^UTILITY(U,$J,358.3,19318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19318,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,19318,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,19318,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,19319,0)
 ;;=I80.9^^55^788^178
 ;;^UTILITY(U,$J,358.3,19319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19319,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,19319,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,19319,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,19320,0)
 ;;=D45.^^55^788^179
 ;;^UTILITY(U,$J,358.3,19320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19320,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,19320,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,19320,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,19321,0)
 ;;=C77.3^^55^788^109
 ;;^UTILITY(U,$J,358.3,19321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19321,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,19321,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,19321,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,19322,0)
 ;;=C77.2^^55^788^125
 ;;^UTILITY(U,$J,358.3,19322,1,0)
 ;;=^358.31IA^4^2
